证券代码：000669 证券简称：ST 金鸿 金鸿控股集团股份有限公司投资者关系活动记录表 | 投资者关系活动 | □特定对象调研□分析师会议 | | --- | --- | | 类别 | □媒体采访√业绩说明会 | | | □新闻发布会□路演活动 | | | □现场参观 | | | □其他（请文字说明其他活动内容） | | 参与单位名称及 | 投资者网上提问 | | 人员姓名 | | | 时间 | 年 月 日 2025 5 27 (周二) 下午 15:00~16:30 | | 地点 | 公司通过全景网"投资者关系互动平台"（https://ir.p5w.net） | | | 采用网络远程的方式召开业绩说明会 | | 上市公司接待人 | 1、董事长、董事会秘书郭韬 | | 员姓名 | 2、财务总监牛威 | | | 3、独立董事陈立新 投资者提出的问题及公司回复情况 | | | 公司就投资者在本次说明会中提出的问题进行了回复： 1、郭总，你好，请问一下金鸿后续会有生物医药公司的注 入吗？ | | | 尊敬的投资者您好，公司目前主营业务为天然气综合利用业 | | 投资者关系活动 | 务，感谢您对公司的关注！ | ...

Group 1: Investor Relations Activity Overview - The investor relations activity took place on May 26, 2025, at the company's conference room in Lianyungang, Jiangsu Province [4] - Attendees included representatives from Huaxia Fund and Xinda Securities, along with the company's chairman, general manager, and other key personnel [4] Group 2: Company Operations and R&D - The company conducted a site visit for the research units to observe the production and R&D facilities, including the formulation workshop and raw material drug workshop [5] - The management provided a comprehensive overview of the company's operational status and product development [5] Group 3: Key Questions and Responses - **Question 1**: Information on the innovative drug DYX116 - DYX116 is a first-class new drug developed in collaboration with WuXi AppTec, currently in Phase I clinical trials, expected to complete by the end of 2025 [6] - **Question 2**: Information on the innovative drug DYX216 - DYX216 is also a first-class new drug for treatment of resistant hypertension, with preliminary candidates identified [6] - **Question 3**: R&D plans for 2025 - The company plans to invest approximately CNY 163 million in R&D for 2025, with CNY 85 million allocated for innovative drugs and CNY 78 million for generic drugs [7] Group 4: R&D Focus and Goals - The R&D strategy will focus on chronic disease treatments characterized by metabolic disorders, including diabetes, hypertension, hyperlipidemia, and hyperuricemia [7] - For generic drugs, the company aims to initiate 10 projects, submit 7 formulation varieties and 3 raw material varieties to CDE, and strive for approvals of 6 formulation varieties and 2 raw material varieties [7] - The company will continue to advance projects like DYX116 and DYX216, integrating resources to accelerate the R&D process [7]

Group 1: Investor Relations Activity Overview - The investor relations activity was an earnings briefing held on May 23, 2025, via an online platform [4] - Participants included the company's chairman, general manager, board secretary, and financial officer [5] Group 2: Key Questions and Responses - **Question 1**: Inquiry about the commercialization progress of the new patent for "waste battery non-discharge crushing equipment" **Response**: The company has not yet implemented the commercialization of this technology, focusing instead on polymer material environmental additives [5] - **Question 2**: Measures taken to enhance corporate governance and internal control in the past year **Response**: The company has optimized governance structure and internal controls, improving decision-making efficiency and information disclosure quality [6] - **Question 3**: How the company ensures timely and transparent communication with investors **Response**: The company utilizes earnings briefings and maintains investor hotlines and email contacts to ensure accurate information dissemination [7] - **Question 4**: Plans for financing to support future expansion, particularly in new environmental additive production projects **Response**: The company has completed the main construction of the new project and currently has no financing plans for it [8]

Group 1: Shareholder Concerns - The progress of the equity transfer by Yatai Group is ongoing, requiring compliance with legal procedures and approvals from relevant authorities [1] - The company's stock price has been below net assets for several years, with a cumulative dividend of only 1 yuan per share since last year [2] - The company acknowledges various factors affecting stock price fluctuations, including macroeconomic conditions and investor sentiment [2] Group 2: Value Management Initiatives - The company is committed to implementing the "Quality Return Dual Improvement" action plan, focusing on value creation, communication, and realization [2] - Efforts will be made to enhance core competitiveness and revenue-generating capabilities while ensuring compliance and stable operations [2] - A modern corporate governance mechanism will be established to improve operational efficiency and investor relations [2] Group 3: Dividend and Investment Attraction - The company plans to maintain an active, continuous, and stable dividend policy to enhance investor returns [2] - Various tools will be utilized to increase the attractiveness of long-term investments [2] - The company is closely monitoring market evaluations of its value and will respond to investor demands [2] Group 4: Legal Matters - The ongoing legal dispute with Jilin Dunhua Rural Commercial Bank regarding the "Northeast Securities Changying No. 4 Directional Asset Management Plan" is under review by the Supreme People's Court [3] - As of May 27, 2025, there have been no new developments regarding the litigation [3]

证券代码：002316 证券简称：ST 亚联 吉林亚联发展科技股份有限公司 投资者关系活动记录表 编号：2025-001 | | □特定对象调研 □分析师会议 □媒体采访 □业绩说明会 | | --- | --- | | 投资者关系 活动类别 | | | | □新闻发布会 □路演活动 | | | □现场参观 | | | ☑其他（2025 年吉林辖区上市公司投资者网上集体接待日） | | 活动参与人员 | 参与 2025 年吉林辖区上市公司投资者网上集体接待日活动的投资 | | | 者。 | | 时 间 | 2025 年 05 月 27 日（周二）下午 15:00-16:30。 | | 地 点 | 公司通过全景网"投资者关系互动平台"（https://ir.p5w.net） | | | 采用网络远程的方式召开本次活动。 | | 上市公司接待 | 公司董事长、总经理、财务总监（代）王永彬先生，独立董事吕功 | | 人员姓名 | 华先生，董事会秘书王思邈女士。 | | 交流内容及具 | 投资者提出的问题及公司回复情况 | | | 公司就投资者在本次说明会中提出的问题进行了回复： | | | 1、公司对生物纤维素有新 ...

Group 1: Technology Innovation and R&D Investment - In 2024, the company will focus on breakthroughs in the micro-light imaging field, developing multiple products for night vision and underwater imaging, achieving domestic substitution [2][4]. - R&D investment for 2024 is projected at CNY 75.36 million, marking a significant increase [3][4]. - The company has achieved a maximum precision of 1μm with incremental reflective scales, and a measurement length of 14 meters with closed-loop steel tape measures, facilitating domestic substitution in the gantry machine tool sector [3][4]. Group 2: Financial Performance and Challenges - In 2024, the company reported a revenue of CNY 745 million and a net profit of CNY 66.42 million, affected by a slowdown in cash collection and increased credit impairment losses [11][28]. - The asset-liability ratio remains low, indicating good short-term solvency despite a decrease in cash flow [7][28]. - The company plans to enhance financial strategies to support business development and shareholder value amidst a challenging industry environment [7][28]. Group 3: Market Position and Future Outlook - The company holds a 13% revenue share from the Kuaizhou rocket business, indicating its role in the aerospace sector [6]. - The company aims to deepen its research in imaging technology and expand into ultra-precision optical manufacturing, targeting high-growth sectors like semiconductors [12][28]. - The company is committed to maintaining a collaborative innovation mechanism with the Chinese Academy of Sciences, ensuring R&D investment remains above 12% over the past three years [8]. Group 4: Shareholder Returns and Corporate Governance - The profit distribution plan for 2024 includes a total cash dividend of CNY 16.8 million, reflecting the company's commitment to shareholder returns while ensuring sustainable growth [39]. - The company is actively considering financing options for future projects, including a precision optical center with an estimated investment of CNY 300-500 million [30][31].

Group 1: Financial Performance - In Q1 2025, the company achieved revenue of 354 million CNY, a year-on-year decrease of 3.23% [8] - The net profit attributable to shareholders was 22.11 million CNY, down 15.39% year-on-year, due to insufficient terminal consumer demand and intensified industry competition [8] - The company plans to enhance operational resilience and focus on internal growth to counteract industry cycles [12] Group 2: Product Development and Innovation - The company is focusing on product innovation and management mechanisms to enhance core competitiveness [10] - New products are in mid-batch expansion stages, with applications in consumer electronics, sanitary materials, and instant tea markets [7] - The company aims to optimize product structure and enhance profitability through continuous product iteration and innovation [12] Group 3: Market Expansion Strategies - The company plans to expand market share by targeting specific markets and customizing marketing strategies based on market conditions and customer needs [5] - Current primary markets include South China and East China, with international coverage in East Asia, the Middle East, Latin America, and Southeast Asia [9] - Future plans include exploring new market fields while maintaining a stable operational strategy [9] Group 4: Corporate Governance and Compliance - The company adheres to legal regulations and has established a robust corporate governance structure to prevent corruption [14] - Regular internal audits and compliance training are conducted to ensure adherence to laws and regulations [14] - The company has implemented a whistleblower mechanism to report any misconduct [14] Group 5: Future Outlook and Goals - The 2025 work theme is "Renew and Grow Resiliently," with ten key operational goals aimed at achieving year-on-year growth in all business indicators [12] - The company plans to enhance product quality and increase production efficiency while ensuring safety in operations [12] - The company anticipates a recovery in the domestic consumption market, which will positively impact the BOPP industry [14]

Group 1: Financial Performance and Strategy - The company aims to improve the profit margin of its new energy products through scale effects, cost reduction of key components, and self-reduction of costs via technology [2] - In 2023, the company plans to gradually develop core components for new energy products to enhance competitiveness and profitability [2][3] - The company has implemented cash management for temporarily idle raised funds to improve efficiency and reduce financial costs, ultimately benefiting shareholders [3] Group 2: Research and Development - The company has established a "Liberation Leading" technology brand and aims for world-class R&D capabilities, supported by a team of over 3,000 [3] - It has developed five major technology platforms focusing on low-carbon, electric, intelligent, connected, and high-quality vehicles [3] - The company is recognized as one of the commercial vehicle enterprises mastering world-class core technologies and has obtained ISO9001 and IATF16949 certifications [3] Group 3: Strategic Partnerships and Innovations - The company is actively pursuing technological transformation and has begun testing L4 level unmanned logistics vehicles [4] - It maintains a good cooperative relationship with Huawei and is exploring opportunities for collaboration in intelligent driving technology [4][5] Group 4: Market Position and Shareholder Relations - The company focuses on long-term value and aims to enhance performance while maintaining cash dividends to reward investors [4] - It emphasizes communication with the capital market to improve recognition and maintain a positive market image [4]

Group 1: Company Operations and Financial Status - The company is currently in the construction preparation phase for its astaxanthin project [1] - The board aims to improve the company's operational and financial conditions to enhance overall competitiveness and achieve the goal of lifting the delisting risk warning by 2025 [2] - If the company encounters specific situations outlined in the Stock Listing Rules in 2025, its shares will be terminated from listing [2] Group 2: Core Business Focus - The company's main business operations include agriculture (including astaxanthin) and military industry, which will remain the core areas for future development [3] Group 3: Mergers and Acquisitions - Future merger and acquisition activities will be announced through company announcements [4] - The company is encouraged to expedite mergers or restructuring to strengthen its operations, especially in light of the relaxed policies on mergers and acquisitions [7] Group 4: Legal and Shareholder Issues - The court ruling regarding the financial loan dispute indicates a risk of change in the controlling shareholder, which may affect the company's management and operations [5][7] - The major shareholder's 90,860,000 shares, accounting for 29.18% of the total share capital, are subject to sale to repay debts [5] Group 5: Product Development and Market Strategy - The company is accelerating the construction of the astaxanthin project and increasing investment to build an ecological chain for the astaxanthin industry [7] - The company has launched astaxanthin eggs and is developing skincare products, with collaborations established for further research and development [7]

Group 1: Company Performance and Financial Outlook - The company reported a loss of over 16 million yuan in the first quarter due to challenges in the downstream construction and real estate sectors, with declining prices for titanium dioxide products [4] - The company is actively working to improve operations and aims to achieve profitability with the upcoming sulfuric acid project, expected to contribute profits post-launch [2][3] - The company plans to announce its operating data for the first half of the year by the end of August [3] Group 2: Capital Raising and Shareholder Engagement - The company has received authorization from the shareholders' meeting for a small-scale quick capital increase, which will be considered based on market conditions and company needs [2][3] - There are currently no intended investors or specific investment directions for the capital increase [1][2] Group 3: Shareholder Concerns and Corporate Governance - The controlling shareholder, Jinpu Group, has 100% of its shares under judicial freeze, which may lead to changes in the controlling shareholder or actual controller [2] - The company is focused on improving governance and compliance to enhance overall development quality [3][4] Group 4: Project Updates and Future Plans - The sulfuric acid facility is expected to be operational by June 2025, while the phosphate iron project is 65% complete but has been temporarily halted due to market conditions [4] - The company is exploring various measures to optimize product structure, reduce costs, and enhance sales [2][3][4]